This is among the most important articles that we have published not just because it challenges the current tsunami of polypharmacy that is being thrust upon us,...
In our recent article “The Royal Commission Report is a Scientific and Ethical Failure", we reported on some of its key deficiencies. With the benefit of some...
In his column Biosafety Now, Dr. Simon Wain-Hobson revisits controversial gain of function research conducted in 2014 funded by US NIH contract HHSN26620070001 which successfully managed to transfer...
Technological power holds a perennial fascination for leaders of every persuasion.
The supposed ability to alter the genes of whole populations is the ultimate dream...
Executive Summary
The 2023 rate of new cancer registrations in New Zealand reached an all time record 29,719 new cancer registrations. This was a rate...
Sent personally to CEOs of Southern Cross, FMG, IAG, UniMed/Accuro, NIB and Partners Life
Dear Director
Sometimes information helps us to understand puzzling situations. Business models...
